Effects of carboxyl-terminal methylation on holoenzyme function of the PP2A subfamily.
Effects of carboxyl-terminal methylation on holoenzyme function of the PP2A subfamily.
复制标题
DOI:
10.1042/bst20200177
复制
发表时间:
2020-10-30
影响因子:
3.9
通讯作者:
Kettenbach AN
中科院分区:
文献类型:
--
作者:
Nasa I;Kettenbach AN
Phosphoprotein Phosphatases (PPPs) are enzymes highly conserved from yeast and human and catalyze the majority of serine and threonine dephosphorylation in cells. To achieve substrate specificity and selectivity, PPPs form multimeric holoenzymes consisting of catalytic, structural/scaffolding, and regulatory subunits. For the Protein Phosphatase 2A (PP2A)-subfamily of PPPs, the holoenzyme assembly is at least in part regulated by an unusual carboxyl-terminal methyl-esterification, commonly referred to as “methylation”. Carboxyl-terminal methylation is catalyzed by leucine carboxyl methyltransferase-1 (LCMT1) that utilizes S-adenosyl-methionine (SAM) as the methyl donor and removed by protein phosphatase methylesterase 1 (PME1). For PP2A, methylation dictates regulatory subunit selection and thereby downstream phosphorylation signaling. Intriguingly, there are four families of PP2A regulatory subunits, each exhibiting different levels of methylation sensitivity. Thus, changes in PP2A methylation stoichiometry alters the complement of PP2A holoenzymes in cells and creates distinct modes of kinase opposition. Importantly, selective inactivation of PP2A signaling through the deregulation of methylation is observed in several diseases, most prominently Alzheimer’s disease (AD). In this review, we focus on how methylation of the carboxyl-terminus of the PP2A subfamily (PP2A, PP4, and PP6) regulates holoenzyme function and thereby phosphorylation signaling, with an emphasis on AD.
影响因子:
3.7
作者:
MacKay KB;Tu Y;Young SG;Clarke SG
通讯作者:
Clarke SG